Address: 318 WFM 544, Suite A2, Murphy, TX 75094 Phone: +1 469-782-0165 Useful Resources: Professional Guidelines & Research American Diabetes Association (ADA) Standards of Care : ADA Professional Guidelines FDA Drug Safety Communication GLP-1 Agonists : FDA Safety Information JAMA Network Open Study GLP-1 and Cancer Risk : Original Research Article American Society of Clinical Oncology (ASCO) : Cancer Prevention Guidelines Patient Education Resources American Cancer Society Obesity and Cancer Risk : ACS Obesity Information National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK GLP-1 Information Novo Nordisk Patient Resources : Official Ozempic Information CDC Diabetes Prevention Program : CDC DPP Resources Clinical Decision Support UpToDate GLP-1 Receptor Agonists : Clinical Decision Support Prescribers Digital Reference (PDR) : Drug Information Database American Association of Clinical Endocrinologists : AACE Clinical Guidelines Cancer Screening Guidelines U.S

All batch experiments were conducted at room temperature (25 C)
Egerod KL, Engelstoft MS, Grunddal KV, Nhr MK, Secher A, Sakata I, Pedersen J, Windelv JA, Fchtbauer E-M, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW
Three patients (two female, one male